Specifically, the F3 gene that encodes tissue factor (TF), a major factor involved in the pro-coagulant activity of cancer, was overexpressed approximately 4.5-fold in the VTE group vs. the control group (log2 fold change = 2.16, p < 0.0001; Figure 2A). The gene discussed is TF; the disease is cancer.